Trial Profile
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Bevacizumab
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2015 New trial record